Concepts (199)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 6 | 2020 | 637 | 0.750 |
Why?
|
| Glioma | 3 | 2018 | 136 | 0.600 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2017 | 367 | 0.370 |
Why?
|
| Glioblastoma | 3 | 2020 | 155 | 0.360 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 214 | 0.360 |
Why?
|
| Mixed Tumor, Mesodermal | 1 | 2010 | 2 | 0.360 |
Why?
|
| Neuroectodermal Tumors | 1 | 2010 | 2 | 0.360 |
Why?
|
| Microvessels | 1 | 2009 | 24 | 0.340 |
Why?
|
| Temporal Lobe | 1 | 2009 | 30 | 0.340 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 2 | 2020 | 46 | 0.330 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 96 | 0.330 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 534 | 0.330 |
Why?
|
| Astrocytoma | 2 | 2010 | 29 | 0.320 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 15 | 0.310 |
Why?
|
| Hippocampus | 1 | 2009 | 170 | 0.310 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 21 | 0.310 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 23 | 0.310 |
Why?
|
| Brain | 2 | 2005 | 948 | 0.300 |
Why?
|
| Brain Chemistry | 1 | 2005 | 29 | 0.250 |
Why?
|
| Neurons | 2 | 2009 | 407 | 0.250 |
Why?
|
| Meningeal Neoplasms | 2 | 2017 | 49 | 0.240 |
Why?
|
| Meningioma | 2 | 2017 | 57 | 0.240 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2004 | 5 | 0.240 |
Why?
|
| Lectins | 1 | 2004 | 10 | 0.240 |
Why?
|
| Humans | 26 | 2020 | 32082 | 0.240 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 154 | 0.240 |
Why?
|
| Cell Communication | 1 | 2004 | 30 | 0.230 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 43 | 0.230 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2004 | 9 | 0.230 |
Why?
|
| Middle Aged | 13 | 2018 | 11834 | 0.230 |
Why?
|
| Antigens, CD | 1 | 2004 | 103 | 0.230 |
Why?
|
| Microglia | 1 | 2004 | 57 | 0.230 |
Why?
|
| Sulfones | 2 | 2020 | 21 | 0.220 |
Why?
|
| Indans | 2 | 2020 | 31 | 0.220 |
Why?
|
| Hyperplasia | 1 | 2002 | 41 | 0.210 |
Why?
|
| Cytokines | 1 | 2004 | 256 | 0.210 |
Why?
|
| Dementia | 1 | 2005 | 253 | 0.200 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 327 | 0.200 |
Why?
|
| Female | 16 | 2018 | 19999 | 0.190 |
Why?
|
| Melanoma | 1 | 2002 | 164 | 0.180 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 57 | 0.180 |
Why?
|
| Aged | 10 | 2018 | 10308 | 0.170 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2018 | 5 | 0.160 |
Why?
|
| Genomics | 1 | 2018 | 85 | 0.150 |
Why?
|
| Tumor Burden | 1 | 2017 | 58 | 0.150 |
Why?
|
| Eye Evisceration | 1 | 2017 | 1 | 0.150 |
Why?
|
| Acrylic Resins | 1 | 2017 | 2 | 0.150 |
Why?
|
| Orbital Implants | 1 | 2017 | 3 | 0.150 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 78 | 0.150 |
Why?
|
| Survival Rate | 3 | 2018 | 876 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 40 | 0.140 |
Why?
|
| Orbit | 1 | 2017 | 19 | 0.140 |
Why?
|
| Genome, Human | 1 | 2017 | 132 | 0.140 |
Why?
|
| Adult | 8 | 2017 | 9375 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 148 | 0.140 |
Why?
|
| Hydrogels | 1 | 2017 | 121 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 1325 | 0.130 |
Why?
|
| Ganglioglioma | 1 | 2015 | 6 | 0.130 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 232 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2020 | 606 | 0.130 |
Why?
|
| Male | 12 | 2018 | 19202 | 0.120 |
Why?
|
| Models, Biological | 2 | 2008 | 392 | 0.120 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 4 | 0.110 |
Why?
|
| Cyclin D1 | 1 | 2013 | 14 | 0.110 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 3990 | 0.110 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2013 | 12 | 0.110 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 29 | 0.110 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 414 | 0.100 |
Why?
|
| Transcription Factors | 1 | 2013 | 181 | 0.100 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2012 | 4 | 0.100 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 22 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2012 | 40 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2012 | 29 | 0.100 |
Why?
|
| Disease Progression | 2 | 2018 | 594 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 516 | 0.100 |
Why?
|
| Prognosis | 3 | 2018 | 1496 | 0.090 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 765 | 0.090 |
Why?
|
| Medulloblastoma | 1 | 2010 | 7 | 0.090 |
Why?
|
| Cerebellar Neoplasms | 1 | 2010 | 11 | 0.090 |
Why?
|
| Ploidies | 1 | 2010 | 7 | 0.090 |
Why?
|
| Ependymoma | 1 | 2010 | 4 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 32 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2010 | 36 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2010 | 82 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 55 | 0.090 |
Why?
|
| Esophagitis | 1 | 2009 | 5 | 0.090 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2009 | 1 | 0.090 |
Why?
|
| Collagen Type IV | 1 | 2009 | 8 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2009 | 11 | 0.090 |
Why?
|
| Radial Neuropathy | 1 | 2009 | 11 | 0.090 |
Why?
|
| Sclerosis | 1 | 2009 | 10 | 0.090 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2009 | 15 | 0.090 |
Why?
|
| Radial Nerve | 1 | 2009 | 17 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 38 | 0.090 |
Why?
|
| Mice | 3 | 2020 | 2474 | 0.090 |
Why?
|
| Cell Death | 1 | 2009 | 71 | 0.080 |
Why?
|
| Crohn Disease | 1 | 2009 | 26 | 0.080 |
Why?
|
| Migraine Disorders | 1 | 2010 | 67 | 0.080 |
Why?
|
| Intestines | 1 | 2009 | 61 | 0.080 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2009 | 8 | 0.080 |
Why?
|
| Image Enhancement | 1 | 2009 | 72 | 0.080 |
Why?
|
| Neural Conduction | 1 | 2009 | 91 | 0.080 |
Why?
|
| Animals | 5 | 2020 | 7510 | 0.080 |
Why?
|
| Spinal Nerves | 1 | 2009 | 65 | 0.080 |
Why?
|
| Hemangioma, Capillary | 1 | 2008 | 3 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2012 | 356 | 0.080 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2008 | 11 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2008 | 10 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 8 | 0.080 |
Why?
|
| Monosomy | 1 | 2008 | 5 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 15 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 40 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2010 | 469 | 0.070 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 193 | 0.070 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2005 | 2 | 0.060 |
Why?
|
| Neurofibrillary Tangles | 1 | 2005 | 6 | 0.060 |
Why?
|
| tau Proteins | 1 | 2005 | 41 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 95 | 0.060 |
Why?
|
| Base Sequence | 1 | 2005 | 252 | 0.060 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2005 | 29 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 288 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 10 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 317 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1187 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2004 | 2 | 0.060 |
Why?
|
| Keratin-20 | 1 | 2004 | 6 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 11 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2004 | 9 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 50 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 48 | 0.060 |
Why?
|
| Ligands | 1 | 2004 | 81 | 0.060 |
Why?
|
| Child | 3 | 2017 | 2439 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2004 | 81 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2005 | 462 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 36 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 109 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 166 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2004 | 292 | 0.060 |
Why?
|
| Genotype | 1 | 2005 | 733 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 210 | 0.050 |
Why?
|
| Mutation | 2 | 2017 | 485 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 943 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2004 | 507 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 629 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2004 | 827 | 0.050 |
Why?
|
| Adolescent | 2 | 2017 | 3568 | 0.050 |
Why?
|
| Macrophages | 1 | 2002 | 188 | 0.050 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2020 | 114 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2020 | 290 | 0.040 |
Why?
|
| Cell Movement | 1 | 2020 | 169 | 0.040 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 13 | 0.040 |
Why?
|
| RNA Interference | 1 | 2018 | 76 | 0.040 |
Why?
|
| Cell Line, Tumor | 1 | 2020 | 725 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 114 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2018 | 72 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2020 | 604 | 0.040 |
Why?
|
| DNA Repair | 1 | 2017 | 64 | 0.040 |
Why?
|
| Injections | 1 | 2017 | 64 | 0.040 |
Why?
|
| Rabbits | 1 | 2017 | 197 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2017 | 3505 | 0.030 |
Why?
|
| Salvage Therapy | 1 | 2015 | 134 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 917 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 1061 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 4 | 0.030 |
Why?
|
| G2 Phase | 1 | 2013 | 17 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 447 | 0.030 |
Why?
|
| Mitosis | 1 | 2013 | 25 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 22 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1267 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2013 | 42 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 560 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1020 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3304 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2013 | 111 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 261 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 208 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 220 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 261 | 0.030 |
Why?
|
| Radiometry | 1 | 2012 | 40 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 162 | 0.020 |
Why?
|
| Apoptosis | 1 | 2013 | 353 | 0.020 |
Why?
|
| Craniopharyngioma | 1 | 2010 | 8 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 41 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 35 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 17 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 12 | 0.020 |
Why?
|
| Vasculitis | 1 | 2009 | 24 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 21 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 51 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 2009 | 28 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2008 | 6 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2008 | 21 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2008 | 21 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 93 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 378 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 673 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 881 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2263 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 1427 | 0.010 |
Why?
|